Emalex Biosciences
Get Full AccessDescription
- Emalex Biosciences, LLC is a biopharmaceutical company dedicated to the development of new treatments for rare and orphan neurological conditions. Ecopipam, its first development candidate, is a novel compound that has been studied as a potential treatment for many central nervous system (CNS) disorders, including pediatric Tourette Syndrome. The latter is a childhood-onset neurodevelopmental condition characterized by motor and vocal tics for which very few safe and effective therapies exist.
-
Headquarters:330 North Wabash Avenue Suite 3500, Chicago, Illinois, United States
More -
Phone Number:
-
Website: http://www.emalexbiosciences.com
-
Employees:7
-
Revenue:$1 - 10M
-
Legal Name:Emalex Biosciences
-
Emalex Biosciences's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Emalex Biosciences
-
Where are Emalex Biosciences's Headquarters?
Emalex Biosciences's Headquarters are in 330 North Wabash Avenue Suite 3500,Chicago,Illinois,United States
-
What is Emalex Biosciences's official website?
Emalex Biosciences's official website is http://www.emalexbiosciences.com
-
What is Emalex Biosciences's Revenue?
Emalex Biosciences's revenue is $1 - 10M
-
What is Emalex Biosciences's NAICS code?
Emalex Biosciences's NAICS code is 541713
-
How many employees are working in Emalex Biosciences
Emalex Biosciences has 7 employees
-
What is Emalex Biosciences's Industry?
Emalex Biosciences is in the industry of Biotechnology
-
Who is Emalex Biosciences's Chief Medical Officer?
Emalex Biosciences's Chief Medical Officer is Atul Mahableshwarkar
-
Who is Emalex Biosciences's Senior Vice President?
Emalex Biosciences's Senior Vice President is Paul Reinfelds